Cargando…
In Vitro Sensitivity to Venetoclax and Microenvironment Protection in Hairy Cell Leukemia
Current standard treatment of patients with hairy cell leukemia (HCL), a chronic B-cell neoplasia of low incidence that affects the elderly, is based on the administration of purine analogs such as cladribine. This chemotherapy approach shows satisfactory responses, but the disease relapses, often r...
Autores principales: | Vereertbrugghen, Alexia, Colado, Ana, Gargiulo, Ernesto, Bezares, Raimundo Fernando, Fernández Grecco, Horacio, Cordini, Gregorio, Custidiano, Maria del Rosario, François, Jean-Hugues, Berchem, Guy, Borge, Mercedes, Paggetti, Jerome, Moussay, Etienne, Gamberale, Romina, Giordano, Mirta, Morande, Pablo Elías |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350736/ https://www.ncbi.nlm.nih.gov/pubmed/34381700 http://dx.doi.org/10.3389/fonc.2021.598319 |
Ejemplares similares
-
Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia
por: Colado, Ana, et al.
Publicado: (2021) -
Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia
por: Sarapura Martinez, Valeria J., et al.
Publicado: (2023) -
The protective role of the microenvironment in hairy cell leukemia treatment: Facts and perspectives
por: Gargiulo, Ernesto, et al.
Publicado: (2023) -
Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia
por: Podaza, Enrique, et al.
Publicado: (2020) -
Revisiting the role of interleukin-8 in chronic lymphocytic leukemia
por: Risnik, Denise, et al.
Publicado: (2017)